What have we learned from ICON1 and ACTION?

International Journal of Gynecological Cancer

Volumn 13, Issue SUPPL. 2, 2003, Pages 140-143

  Colombo, N ^a   Pecorelli, Sergio ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Adjuvant treatment; Early ovarian cancer; Surgical staging

Indexed keywords

PLATINUM;

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; MULTICENTER STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SURVIVAL ANALYSIS;

EID: 1242275170     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2003.13366.x     Document Type: Conference Paper

References (9)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. Trope C, Kaern J, Hogberg T et al. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. Ann Oncol 2000;11:281-8.
3. Dent SF, Klaassen D, Pater JL et al. Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada. Ann Oncol 2000;11:65-8.
4. Hreshchyshyn MM, Park RC, Blessing JA et al. The role of adjuvant therapy in Stage I ovarian cancer. Am J Obstet Gynecol 1980;138:139-45.
5. Vergote I, De Brabander J, Fyles A et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176-82.
6. Bolis G, Colombo N, Pecorelli S et al. Adjuvant treatment for early epithelial ovarian cancer: results of two randomized trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica. Ann Oncol 1995;9:887-93.
7. Trimbos JB, Vergote I, Bolis G et al. European Organization for Research and Treatment of Cancer - adjuvant chemotherapy in ovarian neoplasm. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer - Adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst 2003;95:113-25.
8. Trimbos JB, Parmar M, Vergote I et al. International Collaborative Ovarian Neoplasm Trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst 2003;95:105-12.
9. Young RC, Walton LA, Ellenberg SS et al. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 1990;322:1021-7.